Whether you are developing a traditional small molecule drug, or advanced therapies such as cell and gene therapies, Amplifybio is a CRO with the experience and capabilities to guide you through a single study or a full IND-enabling program. Our 220,000 square foot facility that includes 64 vivarium rooms has been in operation for 11 years and is led by scientists with over 30 years experience in CRO services as Battelle. Since spinning off as Amplifybio, we have expanded our scientific staff and platform capabilities to serve a broader range of study end points and meet critical timelines.
By understanding your commercial goals early, we design the most efficient path to achieve them. Our team of scientists with diverse and deep expertise in virology, immunology, molecular biology, pathology, regulatory compliance and method development will be true and accessible partners through the duration of your project.
Lean on our experience across multiple species to assist you in devising the most appropriate study strategy. Immunodeficient, immunocompromised and transgenic or other genetically modified animal models are also available.
With the expertise to design the right study for every model and flexibility for data-driven implementation, AmplifyBio is your partner to trust for Preclinical Contract Research Organization Services. Talk with us and discover how we can support your study and compliance requirements.